|
GGCX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62210000986818E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.95680155307332E-11 |
| Normal-vs-Stage2 |
3.193600E-02 |
| Normal-vs-Stage3 |
1.901400E-01 |
| Normal-vs-Stage4 |
8.280200E-03 |
| Stage1-vs-Stage2 |
2.744000E-01 |
| Stage1-vs-Stage3 |
7.120200E-02 |
| Stage1-vs-Stage4 |
7.023600E-01 |
| Stage2-vs-Stage3 |
5.023800E-01 |
| Stage2-vs-Stage4 |
3.853600E-01 |
| Stage3-vs-Stage4 |
1.855630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.54740004038234E-09 |
| Normal-vs-AfricanAmerican |
4.72139999985188E-07 |
| Normal-vs-Asian |
1.426820E-01 |
| Caucasian-vs-AfricanAmerican |
9.519400E-01 |
| Caucasian-vs-Asian |
8.916800E-01 |
| AfricanAmerican-vs-Asian |
8.927200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.74651437545981E-12 |
| Normal-vs-Female |
6.842400E-02 |
| Male-vs-Female |
2.197600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.9945000053836E-08 |
| Normal-vs-Extreme_Weight |
5.80635539648711E-12 |
| Normal-vs-Obese |
1.903090E-03 |
| Normal-vs-Extreme_Obese |
2.710500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.375400E-01 |
| Normal_Weight-vs-Obese |
6.034400E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.839200E-01 |
| Extreme_Weight-vs-Obese |
5.464400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.584200E-01 |
| Obese-vs-Extreme_Obese |
2.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.060600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.93370000018045E-07 |
| Normal-vs-Age(61-80Yrs) |
7.61860019515836E-10 |
| Normal-vs-Age(81-100Yrs) |
9.74420000243725E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.640200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.929970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.496200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.186000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.118100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.495400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.17419979189992E-10 |
| Normal-VS-Type2 PRCC |
6.15210000054489E-07 |
| Normal-VS-KIRP CIMP |
6.375200E-01 |
| Normal-VS-Unclassified PRCC |
3.745900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.583200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.237500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.434210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.981300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.596990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.245980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.78229994599144E-10 |
| Normal-vs-N1 |
6.909200E-01 |
| Normal-vs-N2 |
8.802200E-01 |
| N0-vs-N1 |
1.928170E-02 |
| N0-vs-N2 |
4.377700E-02 |
| N1-vs-N2 |
9.669800E-01 |
|
|
